CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

Two-Day Forum Offers an Opportunity to Network with Industry Leaders Exploring the Future of Cardiovascular Technology, Reviewing Its Breakthroughs, Evaluating the Advanced Solutions Shaping the ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...

MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...

Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...

Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...

Major Insurer Joins UnitedHealthcare in Covering Cleerly's AI-QCT/AI-CPA Technology, Expanding Access to 61 Million Americans Cleerly, a leader in AI-based cardiovascular imaging, today announced that ...

Rapid advancements in the field of virtual reality are leading to new developments in cardiovascular treatment and improved outcomes for patients, according to a review paper published today in JACC: ...